|
Jemal A, Siegel R, Ward E. Cancer statistics, 2008 [J]. CA:A Cancer Journal for Clinicians, 2008(2):71.
|
|
Yin S, Li J, Hu C. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity [J]. International Journal of Cancer, 2007(7):1444.
|
|
Collins A T, Berry P A, Hyde C. Prospective identification of tumorigenic prostate cancer stem cells [J]. Cancer Research, 2005, (23):10946.
|
|
O'Brien C A, Pollett A, Gallinger S. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice [J]. Nature, 2007, (7123):106.
|
|
Eramo A, Lotti F, Sette G. Identification and expansion of the tumorigenic lung cancer stem cell population [J]. Cell Death and Differentiation, 2008(3):504.
|
|
Chen Y C, Hsu H S, Chen Y W. Oct4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells [J]. PLoS One, 2008(7):2637.
|
|
Schrattenholz A, Kiemm M. Neuronal cell culture from human embryonicstem cells as in model for neuroprotection [J]. AITEX, 2007(1):9.
|
|
Kim C F, Jackson E L, Woolfenden A E. Identification of bronchioalveolar stem cells in normal lung and lung cancer [J]. Cell, 2005(6):823.
|
|
Eramo A, Lotti F, Sette G. Identification and expansion of the tumorigenic lung cancer stem cell population [J]. Cell Death and Differentiation, 2008(3):504.
|
|
Pircher A, Khler C M, Skvortsov S. ncreased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer:a methodological challenge and an ongoing debate on the clinical relevance [J]. Oncology Reports, 2008(2):345.
|
|
Sotomayor P, Godoy A, Smith G J. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells [J]. Prostate, 2009(4):401.
|
|
Huang Q, Zhang Q B, Dong J. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro [J]. BMC Cancer, 2008(2):304.
|
下载:
苏公网安备 32100302010246号
